ES2538803T3 - Formas de dosificación resistentes al reflujo gástrico - Google Patents

Formas de dosificación resistentes al reflujo gástrico Download PDF

Info

Publication number
ES2538803T3
ES2538803T3 ES14150121.3T ES14150121T ES2538803T3 ES 2538803 T3 ES2538803 T3 ES 2538803T3 ES 14150121 T ES14150121 T ES 14150121T ES 2538803 T3 ES2538803 T3 ES 2538803T3
Authority
ES
Spain
Prior art keywords
pectin
weight
capsule shell
gelatin
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES14150121.3T
Other languages
English (en)
Spanish (es)
Inventor
Nachiappan Chidambaram
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Banner Life Sciences LLC
Original Assignee
Banner Life Sciences LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banner Life Sciences LLC filed Critical Banner Life Sciences LLC
Application granted granted Critical
Publication of ES2538803T3 publication Critical patent/ES2538803T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES14150121.3T 2005-12-22 2006-12-18 Formas de dosificación resistentes al reflujo gástrico Active ES2538803T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/316,830 US20070148248A1 (en) 2005-12-22 2005-12-22 Gastric reflux resistant dosage forms
US316830 2005-12-22

Publications (1)

Publication Number Publication Date
ES2538803T3 true ES2538803T3 (es) 2015-06-24

Family

ID=38007176

Family Applications (3)

Application Number Title Priority Date Filing Date
ES14150121.3T Active ES2538803T3 (es) 2005-12-22 2006-12-18 Formas de dosificación resistentes al reflujo gástrico
ES06845613.6T Active ES2549858T3 (es) 2005-12-22 2006-12-18 Formas de dosificación resistentes al reflujo gástrico
ES15163491.2T Active ES2687807T3 (es) 2005-12-22 2006-12-18 Formas de dosificación resistentes al reflujo gástrico

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES06845613.6T Active ES2549858T3 (es) 2005-12-22 2006-12-18 Formas de dosificación resistentes al reflujo gástrico
ES15163491.2T Active ES2687807T3 (es) 2005-12-22 2006-12-18 Formas de dosificación resistentes al reflujo gástrico

Country Status (6)

Country Link
US (5) US20070148248A1 (enExample)
EP (3) EP2716283B1 (enExample)
JP (2) JP5627854B2 (enExample)
CA (2) CA2633924C (enExample)
ES (3) ES2538803T3 (enExample)
WO (1) WO2007075475A2 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2498207C (en) * 2002-09-11 2012-03-13 Elan Pharma International Ltd. Gel-stabilized nanoparticulate active agent compositions
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
KR101245604B1 (ko) 2007-11-13 2013-03-21 메리테이지 파마, 인크. 코르티코스테로이드 조성물
US20090143343A1 (en) 2007-11-13 2009-06-04 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
WO2013093630A2 (en) 2011-12-22 2013-06-27 Pronova Biopharma Norge As Gelatin/alginate delayed release capsules comprising omega-3 fatty acids, and methods and uses thereof
WO2013155430A1 (en) * 2012-04-13 2013-10-17 Banner Pharmacaps, Inc. Soft elastic capsules containing tablets and liquid or semisolid fills and methods for their manufacture
JP2014172850A (ja) 2013-03-07 2014-09-22 Capsugel Belgium Nv ハードカプセル製剤
AU2014240170B2 (en) * 2013-03-15 2018-05-17 Patheon Softgels Inc. Silk-based capsules
CA2911643C (en) 2013-05-23 2018-01-16 Barlean's Organic Oils, Llc Rotary die system
MX2016004487A (es) 2013-10-30 2016-11-10 Banner Life Sciences Llc Capsulas blandas de capa entérica que constan de ácidos grasos poli insaturados.
US20150366814A1 (en) * 2014-06-23 2015-12-24 Banner Life Sciences Llc All-natural enteric soft capsules comprising active ingredients
US9895333B2 (en) 2014-06-26 2018-02-20 Patheon Softgels Inc. Enhanced bioavailability of polyunsaturated fatty acids
HUE053962T2 (hu) 2014-09-11 2021-08-30 Gelita Ag Zselatin/pektin részecskék
WO2016056230A1 (ja) * 2014-10-06 2016-04-14 富士カプセル株式会社 腸溶性ソフトカプセルの製造方法
SG11201702752RA (en) 2014-10-06 2017-06-29 Fuji Capsule Co Ltd Method of Manufacturing Enteric Seamless Soft Capsule
KR20170076675A (ko) 2014-10-31 2017-07-04 발린스 오르개닉 오일스, 엘.엘.씨. 소프트젤을 제조하기 위한 방법 및 장치
ITUB20156821A1 (it) * 2015-12-09 2017-06-09 Altergon Sa CAPSULE DI GELATINA MOLLE A RILASCIO pH INDIPENDENTE
CN105534945B (zh) * 2015-12-29 2020-12-25 仙乐健康科技股份有限公司 一种植物型肠溶软胶囊
US20240408025A1 (en) * 2021-09-13 2024-12-12 Nutrition & Biosciences Usa 1, Llc A film-forming composition comprising pectin
DE102022104553A1 (de) * 2022-02-25 2023-08-31 Gelita Ag Magensaftresistente Kapsel und deren Verwendung

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58172313A (ja) 1982-04-01 1983-10-11 Morishita Jintan Kk 腸溶性軟カプセル
JPS58194810A (ja) * 1982-05-07 1983-11-12 Morishita Jintan Kk コ−テイング軟ミニカプセル
US4719112A (en) * 1982-10-29 1988-01-12 Warner-Lambert Company Foam capsules
US4518433A (en) * 1982-11-08 1985-05-21 Fmc Corporation Enteric coating for pharmaceutical dosage forms
US4816259A (en) * 1987-02-12 1989-03-28 Chase Chemical Company, L.P. Process for coating gelatin capsules
US6482516B1 (en) * 1993-07-20 2002-11-19 Banner Pharmacaps, Inc. Enrobed tablet
US5146730A (en) * 1989-09-20 1992-09-15 Banner Gelatin Products Corp. Film-enrobed unitary-core medicament and the like
US5264223A (en) * 1990-03-29 1993-11-23 Japan Elanco Company, Ltd. Hard capsule for pharmaceutical drugs and method for producing the same
JPH0427352A (ja) * 1990-05-22 1992-01-30 Fuji Capsule Kk 健康食品用腸溶性軟カプセル
DE4018247A1 (de) * 1990-06-07 1991-12-12 Lohmann Therapie Syst Lts Herstellungsverfahren fuer schnellzerfallende folienfoermige darreichungsformen
US5164184A (en) * 1990-10-11 1992-11-17 Kim Young S Process for the preparation of pharmaceutical liquid composition containing Bezoar bovis
JPH05245366A (ja) * 1992-03-04 1993-09-24 Morishita Jintan Kk 内側面が非水溶化された皮膜を有するシームレスカプセルとその製造方法
MX9301823A (es) * 1992-03-30 1994-01-31 Alza Corp Composicion para el suministro de liberacion controlado de un agente biologicamente activo.
NZ244796A (en) * 1992-08-18 1995-05-26 Scherer Corp R P Capsule shell of soft gelatin contains a medicament and has a removable tab
US5330759A (en) * 1992-08-26 1994-07-19 Sterling Winthrop Inc. Enteric coated soft capsules and method of preparation thereof
US5431917A (en) * 1992-10-08 1995-07-11 Japan Elanco Company, Ltd. Hard capsule for pharmaceutical drugs and method for producing the same
US5726274A (en) * 1994-12-21 1998-03-10 Basf Corporation Polyurethane polymer or oligomer having carbamate groups, method for its preparation, and coating composition
US20010003647A1 (en) 1995-06-07 2001-06-14 Ji Sun Coreatant-including electrochemiluminescent compounds, methods, systems and kits utilizing same
KR100219918B1 (ko) 1997-07-03 1999-09-01 김윤 대장선택적 약물전달용 조성물
WO1999033924A1 (en) * 1997-12-26 1999-07-08 Warner-Lambert Company Gelatine compositions
MXPA01003197A (es) * 1998-09-28 2004-04-21 Warner Lambert Co Suministro enterico y colonico utilizando capsulas de chpm.
PT1117736E (pt) 1998-09-30 2004-10-29 Warner Lambert Co Composicoes de pelicula de amido modificado
EP1072633A1 (en) 1999-07-22 2001-01-31 Warner-Lambert Company Pullulan film compositions
US6346231B1 (en) * 1999-10-06 2002-02-12 Joar Opheim Flavored gelatin capsule and method of manufacture
KR100379674B1 (ko) * 2000-03-06 2003-04-10 주식회사 서흥캅셀 펙틴과 글리세린의 배합용액을 이용한 셀룰로오스 캅셀 및그의 제조방법
US6620571B2 (en) * 2000-03-17 2003-09-16 Eastman Kodak Company Method for producing microcapsules having improved wall characteristics
CN1141974C (zh) * 2000-06-07 2004-03-17 张昊 结肠定位释放的口服生物制剂
EP1184033A1 (en) * 2000-09-01 2002-03-06 Warner-Lambert Company Pectin film compositions
EP1186626A1 (en) * 2000-09-05 2002-03-13 Warner-Lambert Company Composition for soluble films with a new hydrolyzed polysaccharide
US6683019B2 (en) * 2001-06-13 2004-01-27 Abb Lummus Global Inc. Catalyst for the metathesis of olefin(s)
JP4184278B2 (ja) 2001-11-22 2008-11-19 森下仁丹株式会社 非ゼラチン系カプセル皮膜組成物及びそれを用いたカプセル
NO20021592D0 (no) * 2002-04-04 2002-04-04 Fmc Biopolymer As Polysakkaridkapsler og fremgangsmåte ved fremstilling derav
US20040010069A1 (en) 2002-06-27 2004-01-15 Uniroyal Chemical Company, Inc. Rubber compositions and methods for improving the mooney scorch value and cure rate
DK1545475T3 (da) * 2002-10-01 2014-07-28 Banner Pharmacaps Inc Enterisk sammensætning til fremstillingen af blød kapselvæg
ATE340566T1 (de) 2002-12-05 2006-10-15 Symrise Gmbh & Co Kg Nahtlose gefüllte kapseln
US7396874B2 (en) * 2002-12-06 2008-07-08 Hercules Incorporated Cationic or amphoteric copolymers prepared in an inverse emulsion matrix and their use in preparing cellulosic fiber compositions
CA2510465A1 (en) * 2002-12-18 2004-07-08 Pain Therapeutics Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
KR100505530B1 (ko) * 2003-09-29 2005-08-03 주식회사 서흥캅셀 어류 젤라틴을 이용한 하드 캅셀 및 그의 제조방법
JP4027352B2 (ja) 2004-09-17 2007-12-26 アンリツ株式会社 光ファイバプローブ装置
DE102007039772A1 (de) 2007-08-22 2009-02-26 Cavis Microcaps Gmbh Mikrokapsel und Verfahren zu deren Herstellung
JP5245366B2 (ja) 2007-11-14 2013-07-24 王子ホールディングス株式会社 偏光板およびその製造方法

Also Published As

Publication number Publication date
ES2549858T3 (es) 2015-11-02
ES2687807T3 (es) 2018-10-29
EP1973533A2 (en) 2008-10-01
US8962005B2 (en) 2015-02-24
CA2633924C (en) 2013-11-19
CA2633924A1 (en) 2007-07-05
EP2716283B1 (en) 2015-04-15
JP2013209416A (ja) 2013-10-10
US20170281555A1 (en) 2017-10-05
US20150024044A1 (en) 2015-01-22
CA2798511C (en) 2015-04-14
US20070148248A1 (en) 2007-06-28
EP1973533B1 (en) 2015-07-29
EP2923696B1 (en) 2018-07-11
EP2716283A1 (en) 2014-04-09
CA2798511A1 (en) 2007-07-05
JP5627854B2 (ja) 2014-11-19
EP2923696A1 (en) 2015-09-30
JP2009521269A (ja) 2009-06-04
WO2007075475A2 (en) 2007-07-05
WO2007075475A3 (en) 2007-12-13
US20140072625A1 (en) 2014-03-13
US9693966B2 (en) 2017-07-04
US20100158958A1 (en) 2010-06-24
US9192582B2 (en) 2015-11-24
US10182990B2 (en) 2019-01-22

Similar Documents

Publication Publication Date Title
ES2538803T3 (es) Formas de dosificación resistentes al reflujo gástrico
US8840935B2 (en) Orally administrable films and preparation thereof
Dodane et al. Pharmaceutical applications of chitosan
ES2302926T5 (es) Cápsula blanda masticable
TW200418900A (en) Funtionalized polymers for medical applications
JPH08253411A (ja) 軟質ゼラチン医薬製剤
JPH11506432A (ja) 結腸送達のためのビサコジル投与形態
Lim et al. Current status and advances in esophageal drug delivery technology: influence of physiological, pathophysiological and pharmaceutical factors
JP2022525509A (ja) 消化管粘膜用保護接着剤
Anand et al. Significant biopolymers and their applications in buccal mediated drug delivery
US8734839B2 (en) Liquid compositions for soft sustained-release capsules and method for production
Deshmukh Bridging the gap of drug delivery in colon cancer: the role of chitosan and pectin based nanocarriers system
US20060088590A1 (en) Non-blooming gelatin and non-gelatin formulations
JP7719609B2 (ja) 腸溶性硬質カプセル
TW202203899A (zh) 緩釋軟膠囊
WO2008047857A1 (fr) Procédé de production d'une composition comprenant un composé difficilement soluble dans l'eau incorporé dans une matrice hydrophile et préparation pour une utilisation externe comprenant un agent ou médicament anticancéreux ayant un coefficient de partage octanol/eau (log p) de -3,0 ou plus mais pas plus de 3,0, incorporé
Balavigneswaran et al. Polymeric gels for the controlled drug delivery applications
US10940113B2 (en) Pharmaceutical composition for colon targeting, method for treating a colon-related disease using the same and preparation method thereof
Rupali et al. A Technical Note: on Microspheres
JP2025527319A (ja) コーティングされた腸溶性ソフトゲルカプセル剤
Morales Drug Delivery Systems: Oral Mucosal